Other languages Rohto Pharmaceutical Co.,Ltd.

Equities

4527

JP3982400008

Delayed Japan Exchange Other stock markets 09:03:37 01/05/2024 am IST			5-day change	1st Jan Change
3,088 ^JPY	+0.16%		+3.49%	+8.58%

04/04	Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen	MT
04/04	Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mitsui and Rohto to buy $594 mln Chinese medicines company Eu Yan Sang	04/04
Rohto Pharmaceutical's Profit Climbs 21% in Fiscal Nine Months, Lifts Fiscal-Year Outlook	12/02
Japanese Shares Close Marginally Higher Monday Ahead of Biden-Xi Meeting	13/11
Rohto Pharmaceutical’s Attributable Profit Soars 25.8% in Fiscal H1 on Significant Profit Increases Across Categories	13/11
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Full Year Ending March 31, 2024	10/11
Rohto Pharmaceutical Co.,Ltd. Declares Dividend for the Second Quarter of Fiscal Ending March 31, 2024, Payable on December 7, 2023	10/11
Rohto Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	10/11
Rohto Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	09/23/09
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	09/23/09
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024	09/23/09
Rohto Pharmaceutical's FY23 Profit Rises Nearly 25%	23/23/23
Rohto Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	12/23/12
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024	12/23/12
Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	12/23/12
Rohto Pharmaceutical Co.,Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 14, 2023	12/23/12
Rohto Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	12/23/12
Rohto Pharmaceutical Co. Ltd.: kampioen van het receptvrije geneesmiddel	21/23/21
Nuevas compras en la cartera Inversor Asia	24/23/24
Nouveaux achats dans le portefeuille Investisseur Asie	24/23/24
Rohto Pharmaceutical Co.,Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	20/23/20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Rohto Pharmaceutical Co.,Ltd.

Equities

4527

JP3982400008

Other languages

Filters